Nanosonics is an Australian infection prevention company that has successfully developed and commercialised a unique automated disinfection technology, the trophon device, representing the first major innovation in high level disinfection for ultrasound probes in more than 20 years. The trophon device is fast becoming the global standard of care for ultrasound probe disinfection.
Preventable infections are exactly that – preventable. But many medical institutions are forced to spend time and resources dealing with outbreaks of preventable infections. These infections diminish a patient’s quality of care and undermine a healthcare professional’s capacity to provide this care.
For this reason Nanosonics says it constantly pursues breakthrough innovations with the potential to transform infection prevention: “Our vision is to provide fail-safe infection prevention solutions that protect not only an institution’s quality of care, but more importantly the lives of those they treat. So we pioneer ground-breaking technologies to prevent life-altering infections. We set new standards that redefine best practice. And we strive to be a global leader in infection prevention innovation.”
Nanosonics’ mission is to improve the safety of patients, clinics, their staff, and the environment by transforming the way infection prevention practices are understood and conducted and introducing innovative technologies that deliver improved standards of care.
For more information and to view our range of innovative solutions visit us at this year’s annual BMUS meeting.
This news story has been sponsored by the companies concerned and does not represent the views or opinions of RAD Magazine. Visit our dedicated BMUS conference page to find out more.